Australia approves a new bird flu vaccine

Australian officials have approved a bid flu vaccine developed by CSL. And the government announced a $160 million budget to stockpile additional vaccines to help protect the country from an outbreak. The vaccine will only be used in the event of a pandemic.

Australian government officials appeared to be particularly pleased that they could stockpile a vaccine developed inside the country. According to CSL, Panvax can be adjusted to provide protection against any emerging pandemic. Experts note that the bird flu virus will need to mutate into a new strain in order to spread swiftly among people.

- read the story in the Herald-Sun

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.